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Mammalian organs comprise an extraordinary diversity of cell and tissue types. 
Regenerative organs such as the skin and gastrointestinal tract use resident stem 
cells to maintain tissue function. Organs with less cellular turnover, such as the liver 
and lungs, largely rely on proliferation of committed progenitor cells. In many organs 
injury unveils plasticity both of resident stem cells and differentiated cells. The ability 
of resident cells to maintain and repair organs diminishes with age, yet paradoxically 
cancer risk increases. New therapeutic approaches aim to harness cell plasticity for 
tissue repair and regeneration while avoiding the risk of malignant transformation. 
 
Introduction 
The field of cell and gene therapy is now starting to mature, as reports of clinical 
safety and efficacy in patients has begun to grow1. While the number of patients 
treated is small, autologous human induced pluripotent stem cells (hIPSC) as a 
treatment for macular degeneration appears to be safe2, and the ability of gene 
corrected autologous epidermal cells to provide a long lasting cure for a skin 
blistering disease has been established3. The commercial and academic sectors 
have also been buoyed by the successes of cancer immunotherapies such as CAR T 
cell treatments4. 
 
Cell, tissue and organ replacement is needed to treat irreversible organ failure. Yet in 
many cases of damage or disease, a better strategy might be to maintain and 
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reinvigorate organ function in situ. This is an attractive option because it is likely to 
be less invasive and more cost effective than transplantation. Stimulating 
endogenous repair by manipulating stem cells and/or their niche is of growing 
interest, particularly as we come to understand more about the components of the 
cellular microenvironment5 and start to exploit the recently revealed plasticity of stem 
cells in adult tissues6.  
 
Here we discuss different strategies for tissue repair and regeneration and consider 
the mechanisms by which cell plasticity is induced in adult tissues. We consider the 
extent to which induced plasticity might be beneficial in reversing tissue aging and 
the potential risk of plasticity-associated cancer. Finally we speculate on the 
feasibility of stimulating endogenous repair and regeneration to treat disease. 
 
Some definitions 
The stem cell field has evolved to the point where past terminology and dogma are 
outdated in the context of the adult mammal and so it is worth revisiting some of the 
terminology. ‘Repair’ is probably the most straightforward term because it can be 
defined as restoring damaged tissue to good condition following insults such as 
ageing, disease and injury. Tissues differ widely in their ability to repair, with the skin 
and gastrointestinal tract examples of tissues that repair very effectively and the 
brain a tissue in which repair is highly inefficient. In the case of skin (Fig. 1), while 
repair efficiently restores the barrier properties of the tissue, the repaired tissue may 
not be entirely normal; for example there may be scar formation and the repaired 
skin may be devoid of hair follicles. In situations in which new hair follicles form 
following wounding7,8 we can consider them to have regenerated (Fig. 1). We can 
consider the ongoing replacement of epithelial cells that are shed from the surface of 
the skin or the lumen of the gut to constitute ‘regeneration’, essentially a high rate of 
cell turnover under steady-state conditions. Thus we would distinguish regeneration 
as not being obligatorily linked to tissue repair.  
 
We now appreciate that while daughter cells that exit the stem cell compartment 
become increasingly lineage-restricted, they may retain the potential to revert to a 
stem cell state. This ability of a more differentiated cell to give rise to a stem cell, or 
the interconversion of distinct stem cell populations, constitutes ‘plasticity’ and has 
strong parallels with the terms ‘de-differentiation’ and ‘transdifferentiation’ that are 
well known from classical embryology9 (Fig. 2). Furthermore, the phenomenon of 
plasticity suggests that the historical concepts of cell fate specification and 
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determination are not, as previously thought, irreversible. Plasticity also calls into 
question the meaning of ‘terminal differentiation’, which is classically used to 
describe a unidirectional process by which post-mitotic differentiated cells are formed 
from a stem cell population. When such a cell lacks a nucleus, as in the case of 
human red blood cells or cells in the outer layers of human epidermis, there is no 
doubt that the state of differentiation is ‘terminal’, as in ‘irreversible’. However, there 
are now many examples across organ systems where cells committed to a specific 
lineage can re-enter the stem cell compartment following injury6,10. Therefore it would 
appear that even if the trajectory of a cell is towards a terminal state, different steps 
along the route may be reversible.  
 
Finally, what do we mean by ‘quiescence’? Historically, this refers to cells that are 
not actively dividing and may have arrested in G0 phase of the cell cycle. If such 
cells incorporate a DNA label in S phase they may retain the label over many months 
or even years; however, these DNA label retaining cells are not obligatorily arrested 
in G011. In stem cell biology, quiescence is now generally taken to mean a dormant 
genome (heterochromatinisation and low levels of global transcription), and 
metabolic dormancy (low protein translation and lack of oxidative 
phosphorylation)12,13.  
 
Cell lineage tracing: the caveats 
Inevitably, much of our understanding of the nature and properties of adult tissue 
stem cells comes from lineage tracing studies in mice.  This is powerful technology, 
allowing us not only to trace the progeny of individual cells over many generations, 
but also to selectively ablate or expand specific populations. However, there are 
some technical contstraints that must not be ignored. One is so elementary that it 
should not need to be discussed: it is unwise to assume that a marker that is 
expressed in a particular stem cell population is not also expressed in other cells 
within the tissue. A good example here is Lrig1, which is an excellent epithelial stem 
cell marker in a range of tissues, including the epidermis, yet is also expressed in a 
highly dynamic fashion in a subset of skin fibroblasts14. Except in pathological 
situations, where potentially epithelial cells invade the underlying connective tissue, 
or cells undergo epithelial-mesenchymal transition, the gene of interest can still 
provide a highly useful reporter. Indeed Lgr5 and Lgr6, widely used as stem cell 




Co-expression of the stem cell marker Lgr5 in differentiated cells or de novo 
expression following injury may have led to some confusion as to the source of 
regenerating cells. Following injury, increased numbers of Lgr5-lineage traced cells 
have been seen in proliferative organs such as stomach16 and skin, as well as 
relatively slow cycling organs like the liver17 and pancreas18. In the stomach Lgr5 is 
expressed in stem cells as well as chief cells following injury, and this highlights an 
ongoing debate on whether chief cells contribute to the regenerating gastric epithelim 
(Text Box 1). 	
The use of dual recombinase systems can overcome this weakness since lineage 
tracing relies on co-expression of two factors in the same cell19. This approach was 
used to revisit the concept that biliary epithelial cells can transdifferentiate into 
hepatocytes following injury, a concept for which there are opposite results (Text Box 
1). By using two separately encoded recombinase proteins (Sox9-CreER and Alb-
DreER) they demonstrated that Sox9-expressing biliary epithelial cells did not form 
hepatocytes after injury. This is consistent with the emerging concept that biliary 
epithelial cells give rise to hepatocytes only occurs under conditions when 
hepatocytes are unable to divide20,21.  
 
Other approaches for lineage tracing include barcoding and exploitation of naturally 
occurring DNA mutations. For example, Pei et al22 have recently developed an 
artificial DNA recombination locus (termed Polylox) for barcoding based on Cre-loxP 
recombination. Polylox recombination in situ generates several hundred thousand 
barcodes, allowing tagging of single cells in mice. Pei et al used this for fate mapping 
of haematopoietic stem cells in mice, allowing them to demonstrate that the adult 
haemopoietic stem cell compartment is a mosaic of clones that were present in the 
embryo and that most clones in the adult have multilineage differentiation potential. 
Newly developed CRISPR/Cas-based systems to generate large-scale maps of cell 
lineage in multicellular systems for normal development and disease23. 
 
In terms of human lineage tracing, sun-exposed human skin has been a tractable 
system for many years and recent studies have inferred the clonal architecture of the 
epidermis based on DNA sequencing24,25. In this case, a caveat that has emerged is 
that the interpretation of the data depends on how much skin is sequenced to 
capture the largest mutant clones. When sufficiently large areas of skin are 
sequenced, it is possible to infer the effects of primary and secondary mutations, 
leading to the conclusion that secondary mutations arising at the edge of a mutant 
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clone have a selective growth advantage26. Large scale single cell gene expression 
profiling of adult human tissues will undoubtedly improved our understanding of the 
inter-relationships between cell states, cell types and lineages27. 
 
Cell intrinsic mechanisms of plasticity  
Plasticity of adult tissues can be manifest as dedifferentiation or transdifferentiation 
from one stem cell type into another28 (Fig. 2). While in most cases plasticity is linked 
to injury, this is not an obligatory association. In the epidermis, for example, switching 
between stem cell populations and fate switching between differentiated lineages can 
be induced by β-catenin activation in undamaged epidermis29. It is possible that this 
occurs because the epidermis in which β-catenin is activated can reprogram the 
underlying connective tissue, the dermis, to a neonatal state via secretion of 
signalling molecules such as Sonic hedgehog8,30. In support of this, the hair follicle 
defects resulting from deleting the transcriptional co-activator Blimp1 in the dermis 
are rescued by epidermal β-catenin activation31.  
 
There are also many examples of exploiting transcription factors to induce plasticity 
by modulating gene expression cell autonomously. This is evident in the pancreas, 
which exhibits very limited regenerative potential under homeostatic conditions yet in 
which a latent multipotent cell type can be uncovered within the adult pancreas32. 
Expression of endocrine-promoting transcription factors in the exocrine cells of the 
pancreas triggers their conversion to insulin-expressing cells capable to reversing 
diabetes33. Inactivation of the SCF-type E3 ubiquitin ligase substrate recognition 
component Fbw7 induces pancreatic ductal cells to reprogram into α, δ, and β cells 
and acts by stabilising the transcription factor Ngn3, a known regulator of endocrine 
cell differentiation34.  
 
Injury-induced plasticity 
The induction of pluripotency by the expression of transcription factors demonstrates 
that plasticity can be experimentally induced in virtually all somatic cells. However in 
nature, plasticity is most commonly associated with tissue injury and damage (Text 
Box 1). Injury can be manifest in a number of ways, such as targeted laser ablation35, 
tissue disaggregation10 or full-thickness wounds7,36 in the skin. In the intestine, DTR-
mediated stem cell ablation37 or 5-fluoro-uracil mediated killing of proliferative cells38 
causes secretory and absorptive progenitors to acquire ISC-like properties and 
contribute to regeneration. A rare population of cells in the crypt that appear to be 
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enteroendocrine cells also express ISC markers and can broadly contribute to 
epithelial regeneration following irradiation39. While DTR-mediated killing of 
genetically marked cells is not a normal physiological condition, the effects of 
Helicobacter pylori in the stomach undoubtedly are. Chronic injury caused by 
Helicobacter pylori infection can directly amplify the regenerative response and 
cause a number of epithelial changes including loss of Parietal cells and confusion of 
cellular identity of chief cells40.  
 
Plasticity is not limited to the epithelial compartment of tissues. For example, Plikus 
et al41 have reported regeneration of adipocytes from dermal myofibroblasts during 
skin wound healing. This occurs through interaction with hair follicles that are forming 
in the wound. The hair follicles trigger bone morphogenetic protein (BMP) signaling 
and activation of adipocyte transcription factors. Indeed it has been suggested that 
fibrosis may not be solely a consequence of aberrant signalling but by aberrant 
differentiation of a particular subpopulation of fibroblasts42. 
 
Inflammation and infection induced plasticity  
Microbe- and injury-induced inflammatory responses are mediated by cells of 
the innate immune system, which produce and respond to cytokine mediators and 
other inflammatory signals. Tissue resident cells sense these signals and respond by 
migrating, proliferating and regenerating the tissue43. Many of the mechanisms that 
link inflammation to damage repair and regeneration in mammals are conserved in 
lower organisms, indicating that it is an evolutionarily important process44. In terms of 
immune modulation of stem cells and regeneration, evolutionary advances in the 
immune system appear to be inversely correlated with the ability to fully regenerate 
injured tissues45.  
There are a number of ways in which the immune system can facilitate endogenous 
repair. For example, there is a strong link between macrophage-mediated debris 
clearance and regeneration in the central nervous system (CNS)45 and macrophages 
are essential for effective skin wound healing46. In addition, immune cells can 
activate proliferation: in undamaged skin Notch-mediated communication between 
regulatory T cells (Tregs) and hair follicle stem cells is required for hair follicle 
growth47, while Tregs activate muscle satellite cells following injury45. In addition, 




Another way inflammation facilitates repair is through modulating stem cell regulatory 
proteins like Lgr5. Lgr5 is a Wnt target gene and macrophages are a known source 
of Wnt ligands in a variety of contexts including ulcerative colitis49. Lgr5 is also 
directly regulated by inflammatory mediators. In the intestine, the NfΚβ signaling 
effector Stat5 regulates the increase in Lgr5-expressing intestinal stem cells in 
response to injury. In basal cell carcinoma, Stat3 directly binds to and regulates 
transcription of Lgr550. In the intestine Interleukin-22 acts via Stat3 to promote 
epithelial regeneration51. Therefore immune cells could mediate an increase in 
plasticity through direct regulation of stem cell pathways. 
 
In addition to these roles for inflammation in tissue repair, recent data suggest that 
inflammation can trigger epigenetic memory of injury52 and that innate immune 
signalling can play a role in nuclear reprogramming (‘transflammation’53), for example 
via reactive oxygen species (ROS). If inflamed skin is wounded, heals and is then re-
wounded, the second wound heals more rapidly52. This is because epidermal stem 
cells maintain chromosomal accessibility at key stress response genes that are 
activated by the original inflammatory stimulus. This memory depends on the 
intracellular DNA sensor absent in melanoma 2 (Aim2), which encodes an activator 
of the inflammasome. In the absence of AIM2 or its downstream effectors the 
epidermal memory is erased. More broadly, intracellular nucleic acid sensors can 
discriminate between self- and non-self-nucleic acids54, opening up the possibility 
that pathogens can induce plasticity in adult tissues by a similar mechanism.  
 
Cell-ECM and cell-cell adhesion  
In addition to inducing inflammation, injury induces changes in the adhesive 
interactions between cells and their environment. Epithelial damage can lead to loss 
of basement membrane proteins and deposition of new extracellular matrix with a 
different protein composition. It can also lead to loss of neighbouring cells and 
interactions with new neighbours, linked, for example, to cell migration10. Inevitably, 
the fine patterning of niches, leading to local and spatially distinct signals in 
undamaged tissue55, is destroyed following tissue damage. 
Recent studies demonstrate that physical factors play a key role in determining 
tissue architecture under steady state conditions. For example, the undulations of the 
human epidermal-dermal junction are instructive in epidermal stem cell clustering56. 
Crowding in the epidermal basal layer affects cell shape; a decrease in cortical 
tension and increased cell-cell adhesion trigger differentiation and movement of cells 
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into the suprabasal layers57. Piezo1 plays a role in linking mechanical stretch to 
division of epithelial cells58. One of the key integrators of cell position and cell fate in 
the epidermis and other tissues is YAP activity59,60,61. YAP integrates diverse signals, 
including Notch, Wnt and ECM signals61,62 and intercellular adhesion60. In the mouse 
YAP plays a key role in cell fate transitions during colonic regeneration following 
injury62. The colonic epithelium is transiently reprogrammed into a primitive, fetal-like 
state that is orchestrated by ECM remodelling, FAK/Src signalling and YAP 
activation. The combination of ECM proteins and Wnt ligands is sufficient to sustain 
endogenous YAP/TAZ and induce conversion of cell fate.  
 
One way in which injury can potentially induce plasticity is via modulation of the actin 
cytoskeleton. For example, Rho kinase inhibition expands epithelial stem cells in 
culture, including cells from mammary gland, prostate, intestine and colon63,64. 
Similarly, inhibition of dual SMAD signalling enables long-term expansion of basal 
cells in a variety of epithelia, both in vivo and in vitro65. TGFβ/BMP/SMAD signalling 
is activated in the differentiated cells of multiple epithelia, including lung, mammary 
gland, stomach and epidermis, and is suppressed in basal cells that express the 
transcription factor p63. In lung airway epithelium, SMAD signalling promotes 
differentiation, while SMAD inhibition leads to stem cell hyperplasia. These findings 
are likely to be relevant in epithelial cancers. For example, suprabasal expression of 
the α6β4 integrin in mouse epidermis increases tumour formation in part by relieving 
TGFβ-mediated growth inhibition66. 
 
Aging and regeneration 
Tissue integrity, organ function and regenerative capacity all decline with age67. 
Despite an obvious relevance to human health, there are relatively few studies about 
changes in regeneration/homeostasis with age, possibly due to the technical and 
financial burdens of studying “old” animals. Therefore the causes of this decline are 
not well understood. Likely factors involved include loss of stem cell number and 
proliferative capacity, ECM remodeling towards a more fibrotic phenotype, and 
cumulative DNA damage causing cellular senescence (Fig. 3). It is clear that stem 
cell extrinsic factors such as fibrosis caused by chronic inflammation hasten these 
processes. However there are also cell-intrinsic changes in stem and progenitor cells 
that appear to be largely age associated. Age-related changes in tissue resident 




Some age related changes are cell-intrinsic since stem cells isolated from aged 
patients grow poorly in culture relative to their young counterparts. The cell-intrinsic 
mechanisms driving stem cell aging include loss of telomeres, epigenetic changes68, 
decline in mitochondrial function69 and accumulation of DNA mutations70. In the 
intestine it has been shown that critical telomere shortening inactivates Wnt, which 
results in stem cell failure71. The cellular safeguards to cancer, including programmed 
cell death, senescence and differentiation, might be responsible for reduced stem 
cell number and activity as we age. Tomasetti and Vogelstein70 have discussed how 
mutations are coupled to the number of stem cell replications and this might cause 
the well-known increase in cancer risk with age. An increase in mutation load in stem 
cells would be expected to correlate with increased cell death and senescence, 
resulting in the loss of stem cell number or proliferative capacity.  
 
The therapeutic possibility of rejuvenating aged organs is best exemplified from 
parabiosis experiments. Parabiosis, the surgical linking of the circulatory systems 
between old and young animals, resulted in the restoration of stem cell activity in the 
organs of old mice. Moreover, a single transfusion of old blood causes a rapid loss of 
stem cell activity in young mice, demonstrating the negative effects circulating factors 
in old animals72,73. The effects of parabiosis might directly act on stem cells74 or might 
act to remodel and rejuvenate the niche75. Circulating factors that might modulate the 
niche include extracellular matrix (ECM) proteins, growth factors, or immune cells. In 
the skin, age-associated proteolysis of type XVII collagen results in hair follicle 
minituarisation and epidermal hypertrophy, which can be reversed by reexpressing 
the collagen76,77. Soluble growth factors and cytokines, like Wnt and IL22, can 
reverse age related decline of intestinal stem cells51,78. One of the most recent 
approaches to rejuvenate organs is through the targeted removal of senescent 
cells79. 
 
Plasticity and cancer  
The obvious downside of inducing plasticity for tissue rejuvenation is the risk of 
cancer. Thus inflammation-induced lineage infidelity in the epidermis is transient in 
wounds but persists in cancer36. Specific chromatin states prime cells in squamous 
cell carcinoma to undergo EMT80. A further finding is that neighbouring wild type cells 




There are multiple examples linking cellular plasticity and cancer in the GI tract. In 
the stomach, induction of plasticity in differentiated cells occurs during chronic injury, 
and in response to acute injury, where chief cells co-express mucous neck cell 
markers (TTF2 aka spasmolytic polypeptide), a precancerous lesion termed SPEM 
(spasmolytic polypeptide expressing metaplasia)82. A further example of cancer-
associated plasticity is intestinal metaplasia, where esophagus or stomach 
epithelium converts to an intestinal epithelium. In the case of Barrett’s oesophagus, 
an intestine-like metaplasia and precursor of oesophageal adenocarcinoma is 
triggered by gastro-oesophageal reflux. Recently it has been suggested that 
transitional basal cells at the squamous-columnar junction generate Barrett’s 
oesophagus83.  
 
Therapeutic prospects  
Treatments that target the niche are already being evaluated to treat cancer5,84 and 
this review has highlighted a number of strategies that could be exploited to promote 
tissue regeneration. Looking into the future, computational analysis of cell state 
transitions indicates that it may be possible to stabilise particular cell states – 
whether stem cell, committed cell or differentiated cell – pharmacologically85 (for 
therapeutic benefit. In addition, mining large datasets of single cell gene expression 
profiles86 will likely enhance our understanding of different cell types and states and 
the pathways by which they are specified.  
 
One concern is whether the induction of plasticity will ever be therapeutically 
relevant, given that the proportion of cells in a tissue that exhibit plasticity is often 
exceptionally rare37,38. Time will tell, but it is worth concluding with the observation 
that gastric bypass surgery in humans enhances pancreatic β-cell function and may 
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Figure 1: Epidermal plasticity (A) Location of Lgr5, Lgr6 and Lrig1+ stem cells in 
undamaged adult mouse dorsal epidermis. (B, C) Following wounding the 
interfollicular epidermis may be regenerated in the absence (B) of hair follicles and 
sebaceous glands (epidermal repair) or, alternatively, the interfollicular epidermis and 
adnexal structures re-form, constituting epidermal regeneration (C). (D) Following 
wounding the differentiated cells of the Gata6 lineage that are normally confined to 
the suprabasal layers of the sebaceous duct are able to enter the wound site, 
undergo dedifferentiation and contribute to the stem cell compartment of the 
interfollicular epidermis. 
 
Figure 2: General mechanisms of plasticity (A) Under normal homeostatic 
conditions stem cells self-renew and generate differentiated lineages in a 
unidirectional manner via committed progenitors. The fate of stem cells – self-
renewal or generation of differentiated cells is influenced by signals from the niche, 
including specific cell types, soluble signals and ECM. (B) In the context of tissue 
injury or disease, stem and progenitor cells and their differentiated progeny exhibit 
plasticity, including dedifferentiation and transdifferentiation. This is driven, in part, by 
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altered niche signals, including new interactions with cells of the immune system and 
ECM remodelling. 
 
Figure 3: General mechanisms of aging The balance between stem cell renewal 
and differentiation and the interactions between stem cells and the niche (A) are 
altered with aging (B). Age-associated changes are both cell intrinsic, such as 
accumulation of mutations, and niche-associated, such as fibrotic ECM. 
 
Text Box 1: Examples of plasticity 
Lung28 There are two major compartments in adult lung: the airways and the alveoli. 
In the airway epithelia, differentiated club cells (secretory cells) can directly convert 
into ciliated cells. Basal cells replenish all types of secretory and ciliated cells 
following tissue damage. Club cells can de-differentiate into basal stem cells 
following stem cell ablation. The alveolar epithelium consists of type 1 cells that 
permit gas exchange and surfactant-producing type 2 cells. Type 2 cells generate 
type 1 and type 2 cells under homeostatic conditions and after injury. In addition, 
after injury type 1 cells can generate type 2 stem cells. 
 
Stomach The stomach is regionalized into the proximal corpus and distal antrum 
(pylorus). The corpus epithelium contains differentiated chief and parietal cells, while 
the antrum contains gastrin producing G cells. Antrum stem cells express Lgr588,89, 
whereas corpus stem cells express Sox2, Lrig1, Mist190,91,92. Chief cells are long-
lived, highly specialized, pepsinogen-producing cells and become recruited to 
contribute to epithelial repair following injury16,38. 
 
Liver The liver is comprised of two cell types, hepatocytes and cholangiocytes. A 
subpopulation of Wnt-responsive hepatocytes maintain the liver under steady state 
conditions93. After a partial hepatectomy, the remaining hepatocytes divide until the 
original liver mass is restored and then return to a non-proliferative state94. In 
contrast, when there is acute or chronic damage to hepatocytes such that they are 
unable to proliferate, cholangiocyte-like cells near the bile duct tree regenerate 
hepatocytes and cholangiocytes20,21.  
 
Similarities in regeneration and plasticity across GI organs There are vast 
structural and functional differences in the epithelium of GI organs, ranging from a 
stratified squamous epithelium with little cellular diversity in the oesophagus, to a 
complex glandular mucosa in the stomach, to a columnar epithelium in the intestine 
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containing a diverse mix of absorptive and secretory cell types. Nevertheless, these 
organs share many features. The entire epithelium of the GI tract derives from a 
single layer of embryonic endoderm95 and similar signaling pathways control 
epithelial homeostasis in the different organs. Canonical Wnt signaling is involved in 
maintaining and expanding stem and progenitor cells, whereas BMP and Notch 
signaling promote differentiation of the various epithelial lineages. Indeed there is 
evidence that the Caudal Homeobox transcription factor Cdx2 is the single factor that 
functionally distinguishes an intestinal from a gastric stem cell 96,97. It is not clear why 
GI stem cells have so many similarities, but it could be a primitive epigenetic memory 
due to their shared cellular origin during embryonic development.  
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